These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33235284)

  • 1. Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder.
    Ray LA; Du H; Green R; Roche DJO; Bujarski S
    Neuropsychopharmacology; 2021 Feb; 46(3):519-527. PubMed ID: 33235284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging meta-regression to test if medication effects on cue-induced craving are associated with clinical efficacy.
    Nieto SJ; Du H; Meredith LR; Donato S; Magill M; Ray LA
    Psychopharmacology (Berl); 2024 Aug; 241(8):1679-1689. PubMed ID: 38613685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are medication effects on subjective response to alcohol and cue-induced craving associated? A meta regression study.
    Ray LA; Nieto SJ; Meredith LR; Burnette E; Donato S; Magill M; Du H
    Psychopharmacology (Berl); 2023 Sep; 240(9):1921-1930. PubMed ID: 37452887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-regression of methodological features that predict the effects of medications on the subjective response to alcohol.
    Green R; Du H; Grodin EN; Nieto SJ; Bujarski S; Roche DJO; Ray LA
    Alcohol Clin Exp Res; 2021 Jul; 45(7):1336-1347. PubMed ID: 34120356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology.
    Meredith LR; Burnette EM; Nieto SJ; Du H; Donato S; Grodin EN; Green R; Magill M; Baskerville WA; Ray LA
    Alcohol Clin Exp Res (Hoboken); 2023 Sep; 47(9):1629-1645. PubMed ID: 37423771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel human laboratory model for screening medications for alcohol use disorder.
    Ho D; Towns B; Grodin EN; Ray LA
    Trials; 2020 Nov; 21(1):947. PubMed ID: 33225963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of neuroimmune modulation on subjective response to alcohol in the natural environment.
    Meredith LR; Grodin EN; Montoya AK; Miranda R; Squeglia LM; Towns B; Evans C; Ray LA
    Alcohol Clin Exp Res; 2022 May; 46(5):876-890. PubMed ID: 35362101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Interplay Between Subjective Response to Alcohol, Craving, and Alcohol Self-Administration in the Human Laboratory.
    Green R; Grodin E; Lim AC; Venegas A; Bujarski S; Krull J; Ray LA
    Alcohol Clin Exp Res; 2019 May; 43(5):907-915. PubMed ID: 30860603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta-analysis.
    Ray LA; Green R; Roche DJO; Magill M; Bujarski S
    Addict Biol; 2019 Nov; 24(6):1138-1152. PubMed ID: 31148304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial.
    Ray LA; Bujarski S; Shoptaw S; Roche DJ; Heinzerling K; Miotto K
    Neuropsychopharmacology; 2017 Aug; 42(9):1776-1788. PubMed ID: 28091532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of non-consumption outcome measures in alcohol use disorder treatment.
    Kirouac M; Witkiewitz K
    Addiction; 2019 Jun; 114(6):1086-1092. PubMed ID: 30650471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the Relationship Between Self-Reported Drinking and In-Laboratory Drinking and Craving: Is There Concordance?
    DeMartini KS; Pittman B; Krystal JH; O'Malley SS; Krishnan-Sarin S
    Alcohol Clin Exp Res; 2020 May; 44(5):1151-1157. PubMed ID: 32352581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigm.
    Bujarski S; Jentsch JD; Roche DJO; Ramchandani VA; Miotto K; Ray LA
    Neuropsychopharmacology; 2018 Aug; 43(9):1891-1899. PubMed ID: 29802367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial.
    Burnette EM; Baskerville WA; Grodin EN; Ray LA
    Trials; 2020 Sep; 21(1):779. PubMed ID: 32912290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mifepristone as a pharmacological intervention for stress-induced alcohol craving: A human laboratory study.
    Haass-Koffler CL; Magill M; Cannella N; Brown JC; Aoun EG; Cioe PA; Sinha R; Swift RM; Ciccocioppo R; Leggio L
    Addict Biol; 2023 Jul; 28(7):e13288. PubMed ID: 37369125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving.
    Ray LA; Chin PF; Heydari A; Miotto K
    Psychopharmacology (Berl); 2011 Oct; 217(3):341-51. PubMed ID: 21487653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing alcohol cue-reactivity in treatment-seekers versus non-treatment-seekers with alcohol use disorder.
    Venegas A; Ray LA
    Am J Drug Alcohol Abuse; 2020; 46(1):131-138. PubMed ID: 31295037
    [No Abstract]   [Full Text] [Related]  

  • 18. Moderators of subjective response to alcohol in the human laboratory.
    Nieto SJ; Grodin EN; Ho D; Baskerville WA; Ray LA
    Alcohol Clin Exp Res; 2022 Mar; 46(3):468-476. PubMed ID: 35084054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderation of Prazosin's Efficacy by Alcohol Withdrawal Symptoms.
    Sinha R; Wemm S; Fogelman N; Milivojevic V; Morgan PM; Angarita GA; Hermes G; Fox HC
    Am J Psychiatry; 2021 May; 178(5):447-458. PubMed ID: 33207935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial.
    Grodin EN; Bujarski S; Towns B; Burnette E; Nieto S; Lim A; Lin J; Miotto K; Gillis A; Irwin MR; Evans C; Ray LA
    Transl Psychiatry; 2021 Jun; 11(1):355. PubMed ID: 34120149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.